N. Mackman, Role of tissue factor in hemostasis, thrombosis, and vascular development, Arterioscler Thromb Vasc Biol, vol.24, pp.1015-1037, 2004.

M. Riewald and W. Ruf, Orchestration of coagulation protease signaling by tissue factor, Trends Cardiovasc Med, vol.12, pp.149-54, 2002.

W. Ruf and B. M. Mueller, Tissue factor in cancer angiogenesis and metastasis, Curr Opin Hematol, vol.3, pp.379-84, 1996.

W. Ruf, E. G. Fischer, H. Y. Huang, Y. Miyagi, I. Ott et al., Diverse functions of protease receptor tissue factor in inflammation and metastasis, Immunol Res, vol.21, pp.289-92, 2000.

H. Kato, Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects, Arterioscler Thromb Vasc Biol, vol.22, pp.539-587, 2002.

E. G. Fischer, M. Riewald, H. Y. Huang, Y. Miyagi, Y. Kubota et al., Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor, J Clin Invest, vol.104, pp.1213-1234, 1999.

S. A. Mousa and S. Mohamed, Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy, Oncol Rep, vol.12, pp.683-691, 2004.

F. R. Rickles, S. Patierno, and P. M. Fernandez, Tissue factor, thrombin, and cancer, Chest, vol.124, pp.58-68, 2003.

N. Iversen, A. K. Lindahl, and U. Abildgaard, Elevated plasma levels of the factor Xa-TFPI complex in cancer patients, Thromb Res, vol.105, pp.33-36, 2002.

A. Dahm, A. Van-hylckama-vlieg, B. Bendz, F. Rosendaal, R. M. Bertina et al., Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis, Blood, vol.101, pp.4387-92, 2003.

Y. Miyagi, N. Koshikawa, H. Yasumitsu, E. Miyagi, F. Hirahara et al., cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2, J Biochem (Tokyo), vol.116, pp.939-981, 1994.

L. C. Petersen, C. A. Sprecher, D. C. Foster, H. Blumberg, T. Hamamoto et al., Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor, Biochemistry, vol.35, pp.266-72, 1996.

W. Ruf, E. A. Seftor, R. J. Petrovan, R. M. Weiss, L. M. Gruman et al., Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry, Cancer Res, vol.63, pp.5381-5390, 2003.

C. N. Rao, S. Mohanam, A. Puppala, and J. S. Rao, Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor, Biochem Biophys Res Commun, vol.255, pp.94-102, 1999.

S. D. Konduri, A. Tasiou, N. Chandrasekar, G. L. Nicolson, and J. S. Rao, Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion, Clin Exp Metastasis, vol.18, pp.303-311, 2000.

C. N. Rao, S. S. Lakka, Y. Kin, S. D. Konduri, G. N. Fuller et al., Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas, Clin Cancer Res, vol.7, pp.570-576, 2001.

F. Hube, P. Reverdiau, S. Iochmann, J. Rollin, C. Cherpi-antar et al., Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells, Biol Chem, vol.384, pp.1029-1063, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02127398

S. D. Konduri, K. S. Srivenugopal, N. Yanamandra, D. H. Dinh, W. C. Olivero et al., Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells, Oncogene, vol.22, pp.4509-4525, 2003.

C. N. Rao, T. Segawa, J. R. Navari, L. Xu, S. Srivastava et al., Methylation of TFPI-2 gene is not the sole cause of its silencing, Int J Oncol, vol.22, pp.843-851, 2003.

J. Rollin, S. Iochmann, C. Blechet, F. Hube, R. S. Guyetant et al., Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-smallcell lung cancer, Br J Cancer, vol.92, pp.775-83, 2005.

N. Sato, A. R. Parker, N. Fukushima, Y. Miyagi, C. A. Iacobuzio-donahue et al., Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma, Oncogene, vol.24, pp.850-858, 2005.

M. Z. Wojtukiewicz, E. Sierko, L. Zimnoch, L. Kozlowski, and W. Kisiel, Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue, Thromb Haemost, vol.90, pp.140-146, 2003.

H. S. Chand, X. Du, D. Ma, H. D. Inzunza, S. Kamei et al., The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice, Blood, vol.103, pp.1069-77, 2004.

S. A. Mousa, Low-molecular-weight heparins in thrombosis and cancer: emerging links, Cardiovasc Drug Rev, vol.22, pp.121-155, 2004.